Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
The degree of frailty as a translational measure of health in aging
Frailty is a multiply determined, age-related state of increased risk for adverse health
outcomes. We review how the degree of frailty conditions the development of late-life …
outcomes. We review how the degree of frailty conditions the development of late-life …
Cardiac rehabilitation for heart failure:'Cinderella'or evidence-based pillar of care?
RS Taylor, HM Dalal, AD Zwisler - European Heart Journal, 2023 - academic.oup.com
Cardiac rehabilitation remains the 'Cinderella'of treatments for heart failure. This state-of-the-
art review provides a contemporary update on the evidence base, clinical guidance, and …
art review provides a contemporary update on the evidence base, clinical guidance, and …
2021 update to the 2017 ACC expert consensus decision pathway for optimization of heart failure treatment: answers to 10 pivotal issues about heart failure with …
2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart
Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection …
Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection …
2024 ACC expert consensus decision pathway for treatment of heart failure with reduced ejection fraction: a report of the American College of Cardiology Solution Set …
The 2021 Update to the 2017 American College of Cardiology (ACC) Expert Consensus
Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues …
Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues …
Efficacy and safety of dapagliflozin according to frailty in heart failure with reduced ejection fraction: a post hoc analysis of the DAPA-HF trial
Background: Frailty may modify the risk− benefit profile of certain treatments, and frail
patients may have reduced tolerance to treatments. Objective: To investigate the efficacy of …
patients may have reduced tolerance to treatments. Objective: To investigate the efficacy of …
Frailty and heart failure: State‐of‐the‐art review
At least half of all patients with heart failure (HF) are affected by frailty, a syndrome that limits
an individual ability to recover from acute stressors. While frailty affects up to 90% of patients …
an individual ability to recover from acute stressors. While frailty affects up to 90% of patients …
Frailty status modifies the efficacy of exercise training among patients with chronic heart failure and reduced ejection fraction: an analysis from the HF-ACTION trial
Background: Supervised aerobic exercise training (ET) is recommended for stable
outpatients with heart failure (HF) with reduced ejection fraction (HFrEF). Frailty, a syndrome …
outpatients with heart failure (HF) with reduced ejection fraction (HFrEF). Frailty, a syndrome …
Frailty and effects of a multidomain physical rehabilitation intervention among older patients hospitalized for acute heart failure: a secondary analysis of a randomized …
Importance Frailty is common among older patients with acute decompensated heart failure
(ADHF) and is associated with worse quality of life (QOL) and a higher risk of clinical events …
(ADHF) and is associated with worse quality of life (QOL) and a higher risk of clinical events …
The prevalence and importance of frailty in heart failure with reduced ejection fraction–an analysis of PARADIGM‐HF and ATMOSPHERE
P Dewan, A Jackson, PS Jhund, L Shen… - European Journal of …, 2020 - Wiley Online Library
Aims Frailty, characterized by loss of homeostatic reserves and increased vulnerability to
physiological decompensation, results from an aggregation of insults across multiple organ …
physiological decompensation, results from an aggregation of insults across multiple organ …
Sacubitril/valsartan and frailty in patients with heart failure and preserved ejection fraction
Background Frailty is an increasingly common problem, and frail patients are less likely to
receive new pharmacologic therapies because the risk–benefit profile is perceived to be …
receive new pharmacologic therapies because the risk–benefit profile is perceived to be …